TEVA 250502 16.00P(TEVA250502P16000) Stock Price Today

0.61
-0.26-29.89%

15min DelayClose Apr 29 16:00 ET

0.61High0.61Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Options Newsman

Apr 15 10:18

Columns Options Market Statistics: Ford Stock Rises Despite S&P Downgrade Warning; Options Pop

News Highlights
$Ford Motor (F.US)$ stock rose 4% on Tuesday. The most traded calls are contracts of $9.5 strike price that expire on Apr 17 and the total volume reaching 52,829 with the open interest of 29,276.
Ford, GM, and about a dozen car parts suppliers might have their credit ratings downgraded soon if new tariffs from the Trump administration go into effect, says a report from S&P Global Ratings.
The rep...

With the approaching of the exemption from auto tariffs, how will Trump fulfill his promise?

Movers and Shakers

Apr 7 20:39

Columns Today's Pre-Market Movers and Top Ratings | TSLA, NVDA, MSTR, and More

Morning Movers
Gapping Up
$Teva Pharmaceutical Industries (TEVA.US)$ rose by 4.9% as the company announced the FDA has accepted its filing for AJOVY for the prevention of episodic migraines in pediatric patients.
$Dollar Tree (DLTR.US)$ shares rose 1.3%, outperforming a declining market. Citi upgraded the stock to buy from neutral, calling it a "dark horse winner" in a global trade war.
Gapping Down
$Tesla (TSLA.US)$ led a major ...

With the approaching of the exemption from auto tariffs, how will Trump fulfill his promise?

Teddy123

Apr 7 19:36

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

$Teva Pharmaceutical Industries (TEVA.US)$
Breakthrough: AJOVY Set to Become First CGRP Drug for Child Migraine Prevention

Teddy123

Feb 26 12:54

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

$Teva Pharmaceutical Industries (TEVA.US)$
Can Teva's Injectable UZEDY Revolutionize Bipolar I Disorder Treatment? FDA Now Reviewing

Beckman1

Feb 24 09:27

$Teva Pharmaceutical Industries (TEVA.US)$ what was popping off with all the gap up’s gap down’s on the daily ?